|
Volumn 10, Issue 1, 2003, Pages 25-31
|
Preventing angiographic progression of coronary atherosclerosis with pravastatin.
a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LIPID;
PRAVASTATIN;
ANGIOCARDIOGRAPHY;
ARTICLE;
BIOASSAY;
BLOOD;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CORONARY ARTERY ATHEROSCLEROSIS;
CORONARY BLOOD VESSEL;
DISEASE COURSE;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
PATHOLOGY;
PROSPECTIVE STUDY;
RADIOGRAPHY;
REGRESSION ANALYSIS;
RISK FACTOR;
TREATMENT OUTCOME;
CORONARY ANGIOGRAPHY;
CORONARY ARTERIOSCLEROSIS;
CORONARY VESSELS;
DISEASE PROGRESSION;
ENDPOINT DETERMINATION;
FEMALE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
LIPIDS;
MALE;
MIDDLE AGED;
PRAVASTATIN;
PROSPECTIVE STUDIES;
REGRESSION ANALYSIS;
RISK FACTORS;
TREATMENT OUTCOME;
|
EID: 0038005400
PISSN: 13403478
EISSN: None
Source Type: Journal
DOI: 10.5551/jat.10.25 Document Type: Article |
Times cited : (4)
|
References (0)
|